Loading...
Loading...
Browse all stories on DeepNewz
VisitFL legislative leaders' response to special session by Feb 28, 2025
Supportive • 25%
Opposed • 25%
Neutral • 25%
No response • 25%
Statements from Florida Senate President and House Speaker
DeSantis Calls Special Session on Jan. 27 for Trump's Mass Deportations Amid Legislative Pushback
Jan 13, 2025, 09:00 PM
Florida Governor Ron DeSantis has called for a special legislative session starting January 27 to align state policies with President-elect Donald Trump's anticipated immigration crackdown. DeSantis aims to ensure that state and local officials in Florida actively facilitate Trump's deportation policies, which he says were mandated by the American electorate. The session will also address other issues such as hurricane relief, condominium safety, and reforming the petition and amendment process. However, Florida's legislative leaders, Senate President Ben Albritton and House Speaker Daniel Perez, have criticized the call for the session as 'premature' and 'irresponsible,' arguing that it lacks specific details and could potentially hinder Trump's efforts to implement mass deportations. They assert that the Legislature, not the Governor, should decide when and what legislation to consider, and they are prepared to act once they receive clear guidance from the incoming administration following Trump's inauguration.
View original story
No legislation passed • 25%
Partial support legislation passed • 25%
Full support legislation passed • 25%
Session extended without conclusion • 25%
Immigration Policy • 25%
Education Reform • 25%
Healthcare Policy • 25%
Other • 25%
Withdrawn • 25%
Passed • 25%
Failed • 25%
Postponed • 25%
Civil lawsuit filed • 25%
No legal action taken • 25%
Criminal charges pursued • 25%
Other legal action • 25%
Immigration enforcement • 25%
Agricultural relief • 25%
Other • 25%
Ballot initiative reform • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
New regulations on vaccine transparency • 25%
Other • 25%
No legislative action • 25%
Investigations into pharmaceutical companies • 25%
No significant outcome • 25%
Legislation passed • 25%
Session postponed • 25%
Session canceled • 25%